SITCSection 5
U.S. imports of adrenal cortical hormones and derivatives (SITC 54153) totaled $40.5M in April 2026, traded with 24 countries.
Adrenal Cortical Hormones and Derivatives imports of $40.5M in April 2026 ran 51% above the year-to-date monthly average of $26.8M.
Last updated: April 2026 dataAdrenal cortical hormones — corticosteroids such as cortisone, hydrocortisone, prednisone, dexamethasone, and their synthetic derivatives — are among the most widely used anti-inflammatory and immunosuppressive APIs in global pharmaceutical manufacturing. Imported in bulk form for tablet, injectable, and topical drug production, these substances must meet strict pharmacopeial purity standards and originate from FDA-registered, cGMP-compliant facilities. Certain synthetic corticosteroid APIs have been subject to antidumping proceedings, making origin and pricing documentation important for customs compliance beyond standard drug-import requirements.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
Yes — certain bulk corticosteroid APIs have historically been subject to antidumping proceedings. Importers should check the US International Trade Commission and Commerce Department's active order lists for the specific compound and country of origin before finalizing sourcing arrangements, as antidumping duties can significantly affect landed cost.
Most corticosteroid APIs used in US-marketed drug products must meet United States Pharmacopeia (USP) monograph specifications for identity, assay, impurity limits, and physical characteristics. Importers should request certificates of analysis referencing the applicable USP or equivalent pharmacopeial standard, and confirm that the foreign manufacturer's analytical methods have been validated accordingly.
Supplier Network
Get discovered by U.S. importers searching for HS 54153 — Adrenal Cortical Hormones and Derivatives. Be the first supplier listed.
Monthly import values over time